The East African (Nairobi)
7 August 2007
The Swiss company has withdrawn Viracept, its second line Aids medicine due ti a potentially cancer-causing substance. The global recall of the Aids medicine, Viracept, has sparked the biggest prescription drug return in East Africa, with medicines worth more than $2 million being returned to Nairobi-based Roche Products, the regional distributor.
[ See Article ]
